GlaxoSmithKline Consumer Healthcare Ltd. records high growth for the quarter ended December 31, 2011. Gross Sales up 19% and Profits up by 22%

Press Release
Gurgaon, NCR India, Feb 6, 2012

GlaxoSmithKline Consumer Healthcare Ltd records high growth for the quarter ended December 31, 2011

                                 Gross Sales up by 19% and Profits up by 22%

Highlights for the quarter_______________________________________________________

                Board recommends a total Dividend of 350%   


Overview______________________________________________________________________

GlaxoSmithKline Consumer Healthcare Limited (GSKCH) today declared its financial results for the year ended December 31, 2011. Net sales at Rs 2686 crores recorded a growth of 16% over 2010 with PAT at Rs. 355 crores growing by 18% for the same period and PBT at Rs 540 crores growing by 20%. For the Q4 2011, net sales recorded were Rs. 602 crores, recording a growth of 19% with profits of Rs 97 crores (before tax) recording a growth of 22%and Rs 59 crores (after tax).

The Board of Directors of the Company also recommended a Dividend at the rate of Rs. 35 per equity share of Rs. 10 each for the year ended December 31, 2011.

Commenting on the results, Mr. Zubair Ahmed, MD, GSKCH said, “It is gratifying to note that, quarter after quarter GSK is able to record strong topline growth by leveraging science and innovation. Further ‘insight’ based communication coupled with increased penetration across categories helped the company to record strong growth across brands. Despite high inflation in commodities, cost engineering program helped the company deliver superior results."

GSKCH has been on a fast track growth for the past few years and the momentum for top-line growth has continued in 2011 with GSKCH performing exceedingly well in the last quarter of the year with robust sales and profit growth.

About GlaxoSmithKline Consumer Healthcare Ltd.

GSKCH is an associate of GlaxoSmithKline plc. of U.K, a global science based healthcare company. GSKCH has continually benefited from the technical and marketing inputs that have been available as a consequence of this association. GSKCH is the largest player in the health food drinks industry. The Company with its manufacturing plants located in Nabha, Rajahmundry and Sonepat has a total workforce of about 2900 people.

GSKCH has a strong marketing and distribution network in India comprising over 550 wholesalers and direct coverage of over 6,40,000 retail outlets. Its flagship product, Horlicks, is a widely regarded and highly respected brand for over 100 years. The Company also manufactures and markets Boost, Viva and Maltova and in addition markets and distributes a number of products in diverse categories, which include prominent names such as Eno, Crocin, and Iodex as well as products from the global portfolio like Breathe Right and Sensodyne.

Media Contacts _______________________________________________________________

Sakshi Mathur
Genesis Burson Marsteller
sakshi.mathur@bm.com+91 9999007585

Kuheli Ray
Genesis Burson Marsteller
kuheli.ray@bm.com+91 9999783541